Notable Labs Past Earnings Performance
Past criteria checks 0/6
Notable Labs has been growing earnings at an average annual rate of 39.8%, while the Biotechs industry saw earnings growing at 19% annually. Revenues have been growing at an average rate of 3812.5% per year.
Key information
39.8%
Earnings growth rate
-24.9%
EPS growth rate
Biotechs Industry Growth | 17.0% |
Revenue growth rate | 3,812.5% |
Return on equity | -146.7% |
Net Margin | -3,368.1% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Notable Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 0 | -11 | 10 | 6 |
31 Mar 24 | 0 | -9 | 8 | 5 |
31 Dec 23 | 0 | -11 | 10 | 5 |
30 Sep 23 | 0 | -13 | 8 | 5 |
30 Jun 23 | 0 | -18 | 8 | 5 |
31 Mar 23 | 0 | -18 | 7 | 7 |
31 Dec 22 | 0 | -14 | 5 | 8 |
31 Dec 21 | 0 | -16 | 6 | 11 |
Quality Earnings: NTBL.Q is currently unprofitable.
Growing Profit Margin: NTBL.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NTBL.Q's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare NTBL.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NTBL.Q is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15%).
Return on Equity
High ROE: NTBL.Q has a negative Return on Equity (-146.7%), as it is currently unprofitable.